1. Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes 
Bartlomiej M. Getta, Ashwin Kishtagari, Patrick Hilden, Martin S. Tallman, Molly Maloy, Patrick Gonzales, Hugo Castro-Malaspina, Miguel-Angel Perales, Sergio Giralt, Roni Tamari, Virginia Klimek 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 7, Pages (July 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Clinical progression of all patients. All 362 patients were initially classified by their eligibility to undergo transplantation and subsequently by whether they had an indication to undergo transplantation according to predefined criteria. The number of patients referred for transplantation and the number who underwent transplantation in each group was assessed.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Time to transplantation referral and time to transplantation by age group. Cumulative incidence of time to transplantation referral (A) and time to transplantation (B) stratified by patient age. Among transplantation-eligible patients (n = 294), patients ages ≥65 were less likely to be referred for transplantation (P < .001) and were less likely to undergo transplantation (P < .001).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions